Rhone Ma Holdings Bhd (KLSE:5278) — Market Cap & Net Worth
Market Cap & Net Worth: Rhone Ma Holdings Bhd (5278)
Rhone Ma Holdings Bhd (KLSE:5278) has a market capitalization of $39.02 Million (RM155.41 Million) as of July 23, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #22797 globally and #533 in its home market, demonstrating a 6.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rhone Ma Holdings Bhd's stock price RM0.70 by its total outstanding shares 222014664 (222.01 Million). See reinvestment intensity of Rhone Ma Holdings Bhd to understand how much of operating cash flow is reinvested back into capital assets.
Rhone Ma Holdings Bhd Market Cap History: 2016 to 2026
Rhone Ma Holdings Bhd's market capitalization history from 2016 to 2026. Data shows growth from $38.64 Million to $39.02 Million (1.41% CAGR).
Rhone Ma Holdings Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rhone Ma Holdings Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.17x
Rhone Ma Holdings Bhd's market cap is 0.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.72x
Rhone Ma Holdings Bhd's market cap is 2.72 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $38.64 Million | $119.20 Million | $9.17 Million | 0.32x | 4.22x |
| 2017 | $39.32 Million | $137.49 Million | $13.91 Million | 0.29x | 2.83x |
| 2018 | $35.94 Million | $135.24 Million | $10.07 Million | 0.27x | 3.57x |
| 2019 | $32.76 Million | $119.06 Million | $8.64 Million | 0.28x | 3.79x |
| 2020 | $40.28 Million | $146.68 Million | $7.28 Million | 0.27x | 5.53x |
| 2021 | $37.59 Million | $169.43 Million | $11.27 Million | 0.22x | 3.34x |
| 2022 | $36.07 Million | $198.15 Million | $12.74 Million | 0.18x | 2.83x |
| 2023 | $37.10 Million | $202.93 Million | $12.08 Million | 0.18x | 3.07x |
| 2024 | $37.62 Million | $211.41 Million | $12.31 Million | 0.18x | 3.06x |
| 2025 | $38.46 Million | $223.68 Million | $14.16 Million | 0.17x | 2.72x |
Competitor Companies of 5278 by Market Capitalization
Companies near Rhone Ma Holdings Bhd in the global market cap rankings as of July 23, 2026.
Key companies related to Rhone Ma Holdings Bhd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #507 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #523 globally with a market cap of $51.27 Billion USD ( CN¥350.40 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #622 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #507 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #523 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $51.27 Billion | CN¥54.93 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.05 |
| #622 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.80 |
Rhone Ma Holdings Bhd Historical Marketcap From 2016 to 2026
Between 2016 and today, Rhone Ma Holdings Bhd's market cap moved from $38.64 Million to $ 39.02 Million, with a yearly change of 1.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM39.02 Million | +1.45% |
| 2025 | RM38.46 Million | +2.22% |
| 2024 | RM37.62 Million | +1.41% |
| 2023 | RM37.10 Million | +2.86% |
| 2022 | RM36.07 Million | -4.05% |
| 2021 | RM37.59 Million | -6.68% |
| 2020 | RM40.28 Million | +22.95% |
| 2019 | RM32.76 Million | -8.84% |
| 2018 | RM35.94 Million | -8.59% |
| 2017 | RM39.32 Million | +1.76% |
| 2016 | RM38.64 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 22nd, 2026 the market cap of Rhone Ma Holdings Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.02 Million USD |
| MoneyControl | $39.02 Million USD |
| MarketWatch | $39.02 Million USD |
| marketcap.company | $39.02 Million USD |
| Reuters | $39.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Rhone Ma Holdings Bhd
Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory servic… Read more